February 2025 - Seleniumfacts.com

Many elderly adults have low serum selenium concentrations. This is especially true in the United Kingdom and much of Europe and the Middle East [Stoffaneller & Morse 2015]. Now, a published report shows that over 80 % of the 85-year-old adults in a study in northeastern England had suboptimal serum selenium and selenoprotein P concentrations. Over 40 % had deficient selenium status, judged by reference values derived from studies of healthy adults in all age categories [Perri 2024].

Elderly man — **Elderly study participants in England, men especially, were found to have suboptimal (80%) or deficient (40%) serum levels of selenium.**

Suboptimal serum selenium status was defined as 70 mcg/L or lower. Serum selenium deficiency was defined as 45 mcg/L or lower.

The researchers observed a linear association between serum selenium levels and serum selenoprotein P (SELENOP) levels. SELENOP is the primary transport protein carrying selenium from the blood to the peripheral tissues. The findings in this study indicate that most study participants had suboptimal selenium intakes and status. Their diets were not sufficient to saturate the level of circulating SELENOP [Perri 2024]. read more

Selenium from selenium-enriched yeast supplements is more bioavailable than selenium from an inorganic source such as sodium selenite. Selenium from selenium-enriched yeast supplements also tends to be less toxic. These are the conclusions from a 2008 evaluation undertaken by a European Food Safety Authority (EFSA) scientific panel [EFSA 2008].

Glass of beer — **Manufacturers use the yeast Saccharomyces cerevisiae — also known as brewer’s yeast — to produce selenium-enriched yeast supplements.**

To quote directly from the report:

“Despite the higher bioavailability of selenium from organic sources such as selenium-enriched yeast, the toxicity of these organic forms has been shown in a number of studies in experimental animals to be lower than that of inorganic selenite or selenate.”

Study data indicate that organic selenium is more bioavailable than inorganic selenium. Studies in which different selenium preparations have been compared head-to-head point towards a higher bioavailability of selenium from yeast than from inorganic sources [Hadrup & Ravn-Haren 2021]. read more

Milestones in early selenium research

1817 Swedish chemist Jöns Jakob Berzelius discovers selenium

1957 Biochemist Klaus Schwarz shows that selenium in microscopic amounts has a vital importance for mammalian health

1969 Professor J.T. Rotruck discovers that selenium has a biochemical role as a component of the antioxidant enzyme glutathione peroxidase

1969 Professors R.J. Shamberger and D.V. Frost report a possible protective effect of selenium against cancer in humans

1973 Professor J.T. Rotruck identifies the enzyme glutathione peroxidase as a selenium-dependent protein

1977 Professor G.N. Schrauzer publishes cancer mortality correlation studies showing an inverse correlation between dietary intakes of selenium and cancer mortality in 27 countries

1988 Professor G.Q Yang summarizes the lessons learned about the selenium-related endemic diseases Keshan disease and Kashin-Beck disease and about the importance of adequate daily selenium intakes

1989 Professor G.G. Duthie publishes evidence for a role of selenium in the prevention of cardiovascular disease

1993 Researcher W.J. Blot publishes the results of the Nutrition Intervention Trials in Linxian, China, showing that supplementation with a combination of selenium and other antioxidants reduces the risk of cancer

1994 Professor G.N. Schrauzer publishes evidence that selenium is important in the maintenance and therapy of HIV-infected patients

1996 Professor Larry Clark publishes the results of a randomized controlled trial – the Nutritional Prevention of Cancer study -- that shows selenium's cancer-protective effects on colon cancer, lung cancer, and prostate cancer

1997 Professor G.F. Combs summarizes the evidence for the protective effects of selenium against cancer

1999 Professor J.E. Oldfield publishes his Selenium World Atlas, mapping areas of selenium deficiency around the world

2000 Researcher O.A. Levander publishes evidence showing an anti-viral effect of selenium

2002 Researcher R. Gärtner shows that supplementation with selenium reduces inflammation in patients with autoimmune thyroiditis

2002 Researcher Margaret Rayman presents the arguments for increasing selenium intakes to realize selenium’s antioxidant and anti-viral and anti-inflammatory effects as well as selenium’s enhancement of immune function and reproductive success.

Month: February 2025

Low Selenium Status in Elderly Adults

Selenium from Selenium-Enriched Yeast